← 產業報告目錄
Human Microbiome Sequencing Market Size, Share & Trends Analysis Report By Product Type (Kits and Assays, Instruments, Software), By Technology, By Application, By End-User, By Region, And By Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-17頁數 190報告編號 INSIGHTACE-5febc81436
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The global Human Microbiome Sequencing Market is forecasted to expand at a compound annual growth rate of 20.8% throughout the 2024–2031 forecast period.
At its core, Human Microbiome Sequencing pertains to The group of microbes that live on and in our bodies is known as the human microbiome. Stakeholders across the healthcare landscape are risingly turning to these solutions to meet contemporary demands.
Growth is fueled by a convergence of factors: rising awareness among end users, continuous product innovation, and the rising emphasis on efficiency and sustainability within the healthcare sector.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold marked shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and rising investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Human Microbiome Sequencing Market Snapshot
Chapter 4. Global Human Microbiome Sequencing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:
5.2.1. Kits and Assays
5.2.2. Instruments
5.2.3. Software
Chapter 6. Market Segmentation 2: by Technology Estimates & Trend Analysis
6.1. by Technology & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Technology:
6.2.1. Next-Generation Sequencing
6.2.2. Sequencing by Synthesis
6.2.3. Sequencing by Ligation
6.2.4. Other Next-Generation Sequencing Technologies
6.2.5. Traditional Sequencing Technologies
6.2.6. Pyrosequencing
6.2.7. Sanger Sequencing
6.2.8. Other Sequencing Technology
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
7.2.1. Disease Diagnoses
7.2.2. Gastrointestinal Diseases
7.2.3. Metabolic Diseases
7.2.4. Oncology
7.2.5. Infectious Diseases
7.2.6. Neurological Diseases
7.2.7. Other Diseases
7.2.8. Drug Discovery
7.2.9. Consumer Wellness
7.2.10. Omics Analysis
7.2.11. Genome Analysis
7.2.12. Metabolome Analysis
7.2.13. Transcriptome Analysis
7.2.14. Other Omics Analysis
7.2.15. Other Application
Chapter 8. Market Segmentation 4: by End-user Estimates & Trend Analysis
8.1. by End-user & Market Share, 2023 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-user:
8.2.1. Research and Academic Institutions
8.2.2. Pharmaceutical and Biotechnology Companies
8.2.3. Other End Users
Chapter 9. Human Microbiome Sequencing Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Human Microbiome Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
9.1.2. North America Human Microbiome Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
9.1.3. North America Human Microbiome Sequencing Market revenue (US$ Million) by Application, 2024-2031
9.1.4. North America Human Microbiome Sequencing Market revenue (US$ Million) by End-user, 2024-2031
9.1.5. North America Human Microbiome Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.2. Europe
9.2.1. Europe Human Microbiome Sequencing Market revenue (US$ Million) by Product Type, 2024-2031
9.2.2. Europe Human Microbiome Sequencing Market revenue (US$ Million) by Technology, 2024-2031
9.2.3. Europe Human Microbiome Sequencing Market revenue (US$ Million) by Application, 2024-2031
9.2.4. Europe Human Microbiome Sequencing Market revenue (US$ Million) by End-user, 2024-2031
9.2.5. Europe Human Microbiome Sequencing Market revenue (US$ Million) by country, 2024-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Human Microbiome Sequencing Market revenue (US$ Million) by Product Type, 2024-2031
9.3.2. Asia Pacific Human Microbiome Sequencing Market revenue (US$ Million) by Technology, 2024-2031
9.3.3. Asia-Pacific Human Microbiome Sequencing Market revenue (US$ Million) by Application, 2024-2031
9.3.4. Asia Pacific Human Microbiome Sequencing Market revenue (US$ Million) by End-user, 2024-2031
9.3.5. Asia Pacific Human Microbiome Sequencing Market revenue (US$ Million) by country, 2024-2031
9.4. Latin America
9.4.1. Latin America Human Microbiome Sequencing Market revenue (US$ Million) by Product Type, 2024-2031
9.4.2. Latin America Human Microbiome Sequencing Market revenue (US$ Million) by Technology, 2024-2031
9.4.3. Latin America Human Microbiome Sequencing Market revenue (US$ Million) by Application, 2024-2031
9.4.4. Latin America Human Microbiome Sequencing Market revenue (US$ Million) by End-user, 2024-2031
9.4.5. Latin America Human Microbiome Sequencing Market revenue (US$ Million) by country, 2024-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Human Microbiome Sequencing Market revenue (US$ Million) by Product Type, 2024-2031
9.5.2. Middle East & Africa Human Microbiome Sequencing Market revenue (US$ Million) by Technology, 2024-2031
9.5.3. Middle East & Africa Human Microbiome Sequencing Market revenue (US$ Million) by Application, 2024-2031
9.5.4. Middle East & Africa Human Microbiome Sequencing Market revenue (US$ Million) by End-user, 2024-2031
9.5.5. Middle East & Africa Human Microbiome Sequencing Market revenue (US$ Million) by country, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Baseclear B.V.
10.2.2. Beijing Genomics Institute (BGI) Genomics Co., Ltd
10.2.3. Charles River Laboratories International Inc.
10.2.4. Clinical Microbiomics A/S
10.2.5. Eurofins Scientific SE
10.2.6. GENEWIZ, Inc.
10.2.7. Illumina, Inc.
10.2.8. Novogene Corporation
10.2.9. OraSure Technologies, Inc.
10.2.10. Oxford Nanopore Technologies, Inc.
10.2.11. Pacific Biosciences of California, Inc.
10.2.12. QIAGEN N.V.
10.2.13. Second Genome, Inc.
10.2.14. Thermo Fisher Scientific Inc.
10.2.15. Viome, Inc.
10.2.16. CosmosID
10.2.17. Leucine Rich Bio Pvt. Ltd.
10.2.18. Microba
10.2.19. Microbiome Insights Inc.
10.2.20. Molzym GmbH & Co. KG
10.2.21. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們